Latest News about NVO
Recent news which mentions NVO
Jim Cramer Says Eli Lilly Could Replace Tesla In 'Magnificent Seven' List: 'To Ignore...Is To Reject The Facts'
January 22, 2024
From Benzinga
3 Phenomenal Stock-Split Stocks You Should Be Buying Now
January 22, 2024
From InvestorPlace
European Drug Regulator To Consider Expanded Use Of Novo Nordisk's Wegovy Weight-Loss Drug
January 22, 2024
From Benzinga
From Benzinga
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
January 22, 2024
From Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
January 20, 2024
From Motley Fool
Weightloss Drugs Ozempic And Wegovy's Success Sets Novo Nordisk's Owner To Utilize Dividend Windfall For Strategic Investments
January 19, 2024
From Benzinga
These 2 Top Healthcare Stocks Declared Dividend Raises in 2023
January 15, 2024
From Motley Fool
Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024
January 14, 2024
From Motley Fool
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably Wrong
January 13, 2024
From Motley Fool
3 Unstoppable Stocks to Buy in 2024
January 13, 2024
From Motley Fool
Tickers
NVO
From Motley Fool
From Benzinga
Why WW International Stock Plummeted by 9% Today
January 11, 2024
From Motley Fool
FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts
January 11, 2024
From Benzinga
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
From Benzinga
Pfizer’s 2024 Outlook: Is PFE Stock Poised for a Major Rebound?
January 11, 2024
From InvestorPlace
P/E Ratio Insights for Novo Nordisk
January 11, 2024
From Benzinga
Why Eli Lilly Stock Skyrocketed 59% in 2023
January 11, 2024
From Motley Fool
Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments
January 10, 2024
From Benzinga
Looking At Novo Nordisk's Recent Unusual Options Activity
January 10, 2024
Tickers
NVO
From Benzinga
Bring On The Competition In Obesity Drugs: Novo Nordisk CEO Optimistic About Prolonged Patient Adherence to Obesity Drug Wegovy
January 10, 2024
From Benzinga
3 Simple Tricks That Every Investor Should Use (but Most Don't)
January 09, 2024
From Motley Fool
Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles
January 09, 2024
From Benzinga
From Benzinga
Wegovy and Ozempic Maker Novo Nordisk Shares Data From Phase 3 Diabetes Study Of Semaglutide/Insulin Containing Candidate
January 08, 2024
From Benzinga
Could Novo Nordisk Stock Help You Retire a Millionaire?
January 08, 2024
Tickers
NVO
From Motley Fool
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
January 05, 2024
Tickers
NVO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.